首页> 外文期刊>Endocrine journal >Surgical treatment of tertiary hyperparathyroidism after renal transplantation: A 31-year experience in a single institution
【24h】

Surgical treatment of tertiary hyperparathyroidism after renal transplantation: A 31-year experience in a single institution

机译:肾移植术后三级甲状旁腺功能亢进症的外科治疗:在单一机构中拥有31年的工作经验

获取原文
       

摘要

References(32) Cited-By(8) Tertiary hyperparathyroidism (tHPT) most commonly refers to a persistent secondary hyperparathyroidism even after successful renal transplantation. Parathyroidectomy (PTX) is an efficient method for treatment of tHPT. In this study, we examined our 31-year experience with patients who underwent PTX for tHPT after KTX and assessed the effects of PTX on graft function according to the type of surgery. Among 2,981 recipients who underwent renal allograft between April 1979 and Dec. 2010, 15 patients (0.5%) were identified as having tHPT and underwent PTX. Levels of intact parathyroid hormone (iPTH) and serum calcium were measured before and after PTX for evaluation of the therapeutic effect, and glomerular filtration rate (GFR) using the Modification of Diet in Renal Disease (MDRD) equation for investigation of any effect on graft function. One patient showed persistent hyperparathyroidism and hypercalcemia after limited PTX. We experienced 14 successful PTXs, including 3 total PTX with autotransplantations, 8 subtotal PTXs, and 3 limited PTXs. Level of iPTH and serum calcium were at normal range after PTX. Estimated GFR decreased after PTX. Total PTX with autotransplantation showed a tendency of more decrease in the values of iPTH, and GFR after PTX than Subtotal PTX. PTX can cure tHPT-specific symptoms and signs by recovery of hypercalcemia, but may carry the risk of deterioration of kidney graft function. We suspect that subtotal PTX, rather than total PTX with AT, prevent any risk of kidney graft deterioration in surgical treatment of tHPT, and, in selective tHPT patients, limited PTX might be recommended.
机译:参考文献(32)(8)被引用的第三级甲状旁腺功能亢进症(tHPT)最通常是指即使成功进行肾移植后仍持续存在的继发性甲状旁腺功能亢进症。甲状旁腺切除术(PTX)是治疗tHPT的有效方法。在这项研究中,我们检查了我们在接受KTX后进行tHPT的PTX患者的31年经验,并根据手术类型评估了PTX对移植物功能的影响。在1979年4月至2010年12月间接受肾脏同种异体移植的2,981位接受者中,有15位患者(0.5%)被鉴定为患有tHPT并接受了PTX。在PTX之前和之后测量完整的甲状旁腺激素(iPTH)和血清钙水平以评估治疗效果,并使用肾脏疾病饮食调整(MDRD)方程评估肾小球滤过率(GFR)以研究对移植物的任何影响功能。一名患者在PTX受限后表现出持续的甲状旁腺功能亢进和高钙血症。我们经历了14个成功的PTX,包括3个自移植的PTX,8个小计的PTX和3个受限的PTX。 PTX后iPTH和血清钙水平处于正常范围。估计PTX后GFR降低。自体移植的总PTX表现出iPTH和GFR值比小计PTX降低更多的趋势。 PTX可以通过恢复高钙血症来治愈tHPT特有的症状和体征,但可能带来肾移植功能恶化的风险。我们怀疑在进行tHPT的手术治疗中,小计PTX而非总PTX与AT可以防止肾脏移植物恶化的任何风险,并且,对于选择性tHPT患者,可能建议使用有限的PTX。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号